Medexus Pharmaceuticals Inc

Research Medexus Pharmaceuticals Inc (MDP) on Bullrun: market cap CAD 142.16M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMDP
• ExchangeTO
• CountryCanada
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyCAD
• Market capCAD 142.16M
• Financial periodQ4 2025
• RevenueCAD 25.32M
• Net incomeCAD 80.00K
• Free cash flowCAD 7.81M
• Gross margin53.6%

Valuation Snapshot

latest market cap is CAD 142.16M.

About Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases;

Frequently asked questions

What is Medexus Pharmaceuticals Inc's market cap?

Medexus Pharmaceuticals Inc's market capitalization is CAD 142.16M.

What does Medexus Pharmaceuticals Inc do?

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases.